The phase 1/2 clinical trial of Bevacizumab for treatment of Ophthalmic Diseases completed Jul 26, 2023 18:58 HKT/SGT Read More
HanchorBio Announces Taiwan FDA IND Approval for the Multi-Regional Clinical Trial of HCB101 to Treat Solid and Hematological Malignancies Jul 24, 2023 20:19 HKT/SGT Read More
HanchorBio Announces Taiwan FDA IND Approval for the Multi-Regional Clinical Trial of HCB101 to Treat Solid and Hematological Malignancies Jul 24, 2023 19:30 HKT/SGT Read More
RenovoRx and Imugene Announce Collaboration to Deliver Oncolytic Virus Therapy Using Proprietary Trans-Arterial Micro-Perfusion (TAMP) Platform Jul 20, 2023 16:00 HKT/SGT Read More
RenovoRx and Imugene Announce Collaboration to Deliver Oncolytic Virus Therapy Using Proprietary Trans-Arterial Micro-Perfusion (TAMP) Platform Jul 20, 2023 14:00 HKT/SGT Read More
ADICON Holdings Limited One of the Top Three ICL Service Providers in China is Successfully Listed on Main Board of SEHK Jun 30, 2023 14:25 HKT/SGT Read More
ADICON Announces Proposed Listing on the Main Board of The Stock Exchange of Hong Kong at an Offer Price of HK$12.32 Per Share Jun 19, 2023 11:37 HKT/SGT Read More
Avance Clinical at ASCO & BIO 2023: Early Phase Oncology Trials Increasingly Elaborate and Demand More Patients May 30, 2023 10:00 HKT/SGT Read More
아방스 임상, 인생을 변화시키고 생명을 구하는 치료법에 대한 신속한 접근을 위해 글로벌 보건 정상회의 캠페인에 합류 May 25, 2023 16:00 HKT/SGT Read More